文献速递中药与中成药合理使用中医内科

UPLC-MS/MS同时测定大鼠血浆中藿香提取物多成分药代动力学研究

Simultaneous determination of multiple components in rat plasma by UPLC-MS/MS for pharmacokinetic studies after oral administration of Pogostemon cablin extract.
PubMed 文献 · Front Pharmacol · 2024-05-22

本研究建立并验证了UPLC-MS/MS方法,可同时测定大鼠口服藿香提取物后血浆中15种原型成分。方法学显示日内/日间准确度-12.0~14.3%、精密度<11.3%、提取回收率70.6-104.5%、基质效应67.4-104.8%,稳定性RSD<14.1%。该法可用于藿香提取物多成分药代动力学评价,为临床合理用药提供参考。

要点

  • UPLC-MS/MS可同时测定大鼠血浆中藿香提取物15种原型成分。
  • 方法学验证准确度、精密度、回收率、基质效应和稳定性均符合要求。
  • 该法为藿香多成分药代动力学及临床合理用药提供参考。

核心结论

  • 所建立的UPLC-MS/MS方法可同时测定大鼠口服藿香提取物后血浆中15种原型成分,并用于药代动力学评价。

研究设计与样本

  • 研究采用UPLC-MS/MS法,以大鼠口服藿香提取物后的血浆为样本,同时测定15种原型成分。
  • 血浆样品经乙腈蛋白沉淀处理,以淫羊藿苷为内标。

主要发现

  • 日内和日间准确度范围为-12.0~14.3%,精密度小于11.3%。
  • 提取回收率范围为70.6-104.5%,基质效应范围为67.4-104.8%。
  • 稳定性试验相对标准偏差低于14.1%。

关键数值与推荐

  • 15种原型成分包括香草酸、牡荆素、毛蕊花糖苷、异毛蕊花糖苷、金丝桃苷、芹菜素、β-鼠李柠檬素、刺槐素、茵陈素、广藿香酮等。
  • 方法学验证指标:准确度-12.0~14.3%,精密度<11.3%,提取回收率70.6-104.5%,基质效应67.4-104.8%,稳定性RSD<14.1%。

临床怎么用

  • 该法可用于藿香提取物多成分药代动力学研究,为临床安全、有效、合理用药提供参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Introduction: Pogostemon cablin (PC) is used in traditional Chinese medicine and food, as it exerts pharmacological effects, such as immune-modulatory, antibacterial, antioxidant, antitumor, and antiviral. Currently, the pharmacokinetics (PK) studies of PC mainly focus on individual components. However, research on these individual components cannot reflect the actual PK characteristics of PC after administration. Therefore, the simultaneous determination of multiple components in rat plasma using UPLC-MS/MS was used for the pharmacokinetic study after oral administration of PC extract in this study, providing reference value for the clinical application of PC. Methods: In the present study, a reliable and sensitive ultra-high performance liquid chromatography/tandem mass spectrometry (UPLC-MS/MS) method was developed and validated for the simultaneous determination of 15 prototype components (vanillic acid, vitexin, verbascoside, isoacteoside, hyperoside, cosmosiin, apigenin, β-rhamnocitrin, acacetin, ombuin, pogostone, pachypodol, vicenin-2, retusin, and diosmetin-7-O-β-D-glucopyranoside) in rat plasma after oral administration of the PC extract. Plasma samples were prepared via protein precipitation using acetonitrile, and icariin was used as the internal standard (IS). Results: The intra-day and inter-day accuracies ranged from -12.0 to 14.3%, and the precision of the analytes was less than 11.3%. The extraction recovery rate of the analytes ranged from 70.6-104.5%, and the matrix effects ranged from 67.4-104.8%. Stability studies proved that the analytes were stable under the tested conditions, with a relative standard deviation lower than 14.1%. Conclusion: The developed method can be applied to evaluate the PK of 15 prototype components in PC extracts of rats after oral administration using UPLC-MS/MS, providing valuable information for the development and clinical safe, effective, and rational use of PC.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Zhu Y, Ouyang H, Lv Z, et al. Simultaneous determination of multiple components in rat plasma by UPLC-MS/MS for pharmacokinetic studies after oral administration of Pogostemon cablin extract. Front Pharmacol. 2024. PMID: 38841366. doi:10.3389/fphar.2024.1293464

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。